David Einhorn: portfolio of Greenlight Capital

David Einhorn leads Greenlight Capital, which follows a value approach; short sales do not appear in the 13F report.

Source: 13F filing with the US Securities and Exchange Commission dated Aug 14, 2026. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.

You are looking at Q2 2026. Go to the latest filing (Q3 2026)

3.9B USDQ2 2026
Total value of stock positions
3.9B USD
Positions
46
Share of the ten largest
52.8%

The ten largest positions Q2 2026

  1. Green Brick Partners Inc 19.4%unchanged
  2. Fluor Corp 6.2%▼ −1.9%
  3. Core Natural Resources Inc 4.7%▲ +22.9%
  4. Brighthouse Finl Inc 4.6%unchanged
  5. Acadia Healthcare Company In 3.3%▼ −2.6%
  6. Penn Entertainment Inc 3.2%▼ −3.0%
  7. Fortune Brands Innovations I 3.1%new
  8. PG&E Corporation 2.9%unchanged
  9. Centene Corporation 2.7%▼ −39.6%
  10. Graphic Packaging Hldg Co 2.7%▲ +9.4%
Total value of stock positions per quarter, Q2 2013 to Q3 2026 (peak 8.0B USD).
Choose a quarter (54 filings)

All positions Q2 2026

Positions Q2 2026 per 13F filing, 46 of 46
Symbol Weight Shares Reported value Change Held since
Green Brick Partners Inc 19.4% 9,467,383 757.8M USD unchanged Q4 2014 47 quarters
Brighthouse Finl Inc 4.6% 2,842,100 179.9M USD unchanged Q3 2017 36 quarters
SPDR Gold TR 0.8% 83,421 30.7M USD −16.3% reduced Q2 2020 25 quarters
Gopro Inc < 0.1% 1,693,860 1.3M USD unchanged Q1 2021 22 quarters
Gain Therapeutics Inc < 0.1% 566,130 1.1M USD unchanged Q1 2021 22 quarters
Nuvation Bio Inc < 0.1% 34,995 198.8K USD unchanged Q1 2021 22 quarters
Graphic Packaging Hldg Co 2.7% 9,953,430 105.2M USD +9.4% increased Q2 2021 21 quarters
Lakefront Biotherapeutics NV 0.4% 482,746 14.5M USD unchanged Q4 2021 19 quarters
Coya Therapeutics Inc 0.3% 2,335,540 13.7M USD unchanged Q4 2022 15 quarters
Dht Holdings Inc 2.1% 5,034,320 83.2M USD −4.5% reduced Q3 2023 12 quarters
Teva Pharmaceutical Inds Ltd 2.5% 2,886,059 97.8M USD −0.8% reduced Q4 2023 11 quarters
Penn Entertainment Inc 3.2% 5,860,270 125.2M USD −3.0% reduced Q1 2024 10 quarters
Roivant Sciences Ltd 1.9% 2,152,669 76.2M USD unchanged Q1 2024 10 quarters
Liberty Global Ltd 1.4% 4,963,322 56.4M USD unchanged Q1 2024 10 quarters
Capri Holdings Limited 2.3% 4,820,118 89.5M USD −2.2% reduced Q2 2024 9 quarters
Cnh Indl N V 1.2% 4,188,940 47.0M USD unchanged Q3 2024 8 quarters
Acadia Healthcare Company In 3.3% 4,400,641 130.0M USD −2.6% reduced Q4 2024 7 quarters
CNC Centene Corporation 2.7% 1,651,150 106.0M USD −39.6% reduced Q4 2024 7 quarters
TD Synnex Corporation 2.6% 381,042 101.9M USD −20.5% reduced Q4 2024 7 quarters
Core Natural Resources Inc 4.7% 2,283,200 182.7M USD +22.9% increased Q1 2025 6 quarters
Fluor Corp 6.2% 4,658,750 244.1M USD −1.9% reduced Q2 2025 5 quarters
Sotera Health Co 1.9% 4,135,515 73.4M USD +100.2% increased Q2 2025 5 quarters
CI Cigna 0.6% 88,400 24.4M USD unchanged Q2 2025 5 quarters
PCG PG&E Corporation 2.9% 6,632,852 111.6M USD unchanged Q3 2025 4 quarters
Bkv Corp 2.2% 3,095,173 84.7M USD +14.8% increased Q4 2025 3 quarters
HSIC Henry Schein 1.5% 718,550 60.0M USD +19.9% increased Q4 2025 3 quarters
Antero Resources Corp 1.4% 1,574,140 55.3M USD +94.7% increased Q4 2025 3 quarters
DECK Deckers Brands 1.3% 506,398 50.3M USD +5.2% increased Q4 2025 3 quarters
Spectrum Brands Holdings Inc 1.2% 561,438 48.1M USD −13.7% reduced Q4 2025 3 quarters
Slide Ins HLDGS Inc 0.8% 1,686,630 32.7M USD unchanged Q4 2025 3 quarters
Crocs Inc 2.1% 669,140 80.7M USD unchanged Q1 2026 2 quarters
Versant Media Group Inc 1.8% 1,922,172 69.2M USD −36.5% reduced Q1 2026 2 quarters
Dauch Corp 1.7% 12,395,104 67.2M USD +96.4% increased Q1 2026 2 quarters
Stubhub HLDGS Inc 1.4% 4,233,200 54.5M USD unchanged Q1 2026 2 quarters
Resideo Technologies Inc 1.4% 1,699,590 52.9M USD +7.9% increased Q1 2026 2 quarters
VTRS Viatris 1.1% 2,773,470 44.0M USD +52.6% increased Q1 2026 2 quarters
SKYD Skydance Corporation 1.0% 3,926,080 38.7M USD unchanged Q1 2026 2 quarters
Tripadvisor Inc 0.8% 2,361,973 32.4M USD +51.0% increased Q1 2026 2 quarters
Immunovant Inc < 0.1% 93,520 3.6M USD unchanged Q1 2026 2 quarters
Fortune Brands Innovations I 3.1% 2,241,875 123.1M USD new Q2 2026 1 quarter
Versigent PLC 2.4% 2,277,640 95.7M USD new Q2 2026 1 quarter
Primo Brands Corporation 1.8% 2,823,660 69.0M USD new Q2 2026 1 quarter
PYPL PayPal 1.6% 1,424,320 61.5M USD new Q2 2026 1 quarter
Warner Bros Discovery Inc 1.5% 2,246,180 59.9M USD new Q2 2026 1 quarter
Pvh Corporation 1.0% 520,800 38.7M USD new Q2 2026 1 quarter
CMCSA Comcast 0.8% 1,345,780 33.0M USD new Q2 2026 1 quarter

“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.

Breakdown by sector

  • Health Care 6.0%
  • Utilities 2.9%
  • Communication Services 1.8%
  • Financials 1.6%
  • Consumer Discretionary 1.3%
  • not in our coverage 86.5%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close